Bayer AG Launches China Innovation Hub to Boost Local R&D and Global Integration
Bayer AG (ETR: BAYN), a German multinational pharmaceutical and life sciences giant, has announced the...
Bayer
Bayer AG Launches New Life Sciences Incubator in Shanghai to Boost Biotech Ecosystem
Bayer AG (ETR: BAYN, FRA: BAYN, OTCMKTS: BAYRY), a leading German life sciences company, announced...
Bayer’s Finerenone Shows Promise in Heart Failure Treatment, Outperforms Placebo in Phase III Trial
FRANKFURT—Bayer AG (FRA: BAYN) has announced positive results from the Phase III FINEARTS-HF study for...
Bayer AG’s Q2 2024 Global Group Sales Rise 3.1%, Driven by Pharmaceuticals and Consumer Healthcare
Bayer AG (OTCMKTS: BAYZF), a multinational pharmaceutical and life sciences company headquartered in Germany, has...
Bayer’s BAY 3375968 Receives NMPA Approval for Clinical Trial in Advanced Solid Tumors
Bayer AG (ETR: BAYN), a multinational pharmaceutical giant based in Germany, has received clinical trial...
Bayer Restructures China Business into Five Sectors and Six Departments
Bayer (ETR: BAYN), the German pharmaceutical and life sciences giant, has announced a strategic restructuring...
Bayer’s HER2 Targeting Drug BAY 2927088 Earns Breakthrough Designation in China
The Center for Drug Evaluation (CDE) in China has granted Breakthrough Therapy Designation (BTD) to...
Burning Rock Expands Companion Diagnostics Partnership with Bayer for Precision Oncology in China
Burning Rock Ltd (NASDAQ: BNR), a China-based medical technology company, has announced another partnership in...
Bayer’s Consumer Health Division to Invest $83 Million in New Supply Center in China
Bayer (ETR: BAYN)’s Consumer Health Division has entered into an agreement with Qidong city in...
Bayer’s 225Ac-PSMA-Trillium Therapy Begins Early-Stage Clinical Trial for mCRPC
Bayer AG (ETR: BAYN), a multinational pharmaceutical company based in Germany, has this week commenced...
Bayer’s Q1 2024 Report Shows Slight Dip in Sales Amid Pharmaceutical Unit’s Growth
Germany-based Bayer (ETR: BAYN) has released its financial report for the first quarter of 2024,...
Bayer CEO Joins German Chancellor on China Visit, Announces New Investments
Bayer AG (ETR: BAYN, FRA: BAYN, OTCMKTS: BAYRY), a multinational pharmaceutical and life sciences company...
Bayer Partners with Hologic to Develop Contrast-Enhanced Mammography Solution for Breast Cancer Diagnosis
Bayer (ETR: BAYN), a multinational pharmaceutical and life sciences company headquartered in Germany, has announced...
Novartis Announces Layoffs to Streamline Operations and Boost Portfolio Value
Swiss pharmaceutical giant Novartis (NYSE: NVS) is gearing up for a strategic restructuring that will...
Bayer Partners with Google Cloud to Develop AI-Powered Medical Imaging Solutions
Germany’s pharmaceutical and life sciences giant Bayer (ETR: BAYN) has joined forces with US technology...
Luye Pharma’s Subsidiary Boan Biotech Completes Phase III Trial for Eylea Biosimilar BA9101
Shandong Boan Biotechnology Co., Ltd., a subsidiary of China-based Luye Pharma Group (HKG: 2186), has...
Roche Invests EUR 90 Million in New Gene Therapy Center in Germany
Swiss pharmaceutical giant Roche (SWX: RO) has inaugurated a new gene therapy development center in...
Bayer Eliminates C-Level Roles in Restructuring Efforts to Boost Profitability
Germany’s Bayer (ETR: BAYN) has taken significant steps in its restructuring efforts by eliminating 8...
Bayer and Thermo Fisher Partner to Develop Rapid Companion Diagnostics for Precision Oncology
Germany’s Bayer (NYSE: BAYE) has entered into a strategic partnership with U.S. life sciences leader...
Bayer’s Elinzanetant Achieves Primary Endpoint in Late-Stage Menopause Symptom Trial
Bayer (ETR: BAYN), a leading German pharmaceutical company, has announced positive results from a placebo-controlled...